Showing results (211-220 of 510) with videos related to
Sort By:
Pageof 51
The Lancet. Neurology|July 21, 2023
Insights into migraine attacks from neuroimagingRoberta Messina, Maria A Rocca, Peter J Goadsby, et al.Pain Management|December 7, 2020
Eptinezumab for the preventive treatment of migraineMaría Dolores Villar-Martínez, David Moreno-Ajona, Peter J GoadsbyAnnals of the Academy of Medicine, Singapore|May 19, 2020
Emerging Treatment Options for MigraineYi Jing Zhao, Jonathan J Y Ong, Peter J GoadsbyCephalalgia : an International Journal of Headache|August 25, 2017
Comparative effects of traditional Chinese and Western migraine medicines in an animal model of nociceptive trigeminovascular activationYonglie Zhao, Margarida Martins-Oliveira, Simon Akerman, et al.The Journal of Headache and Pain|October 28, 2010
A potential nitrergic mechanism of action for indomethacin, but not of other COX inhibitors: relevance to indomethacin-sensitive headachesOliver Summ, Anna P Andreou, Simon Akerman, et al.Cephalalgia : an International Journal of Headache|May 19, 2025
Amylin and the amylin receptors in migraine: Is there another pathway to target?David Moreno-Ajona, Helin Gosalia, Jan Hoffmann, et al.Archives of Neurology|July 13, 2011
Trigeminal neuropathic pain in a patient with progressive facial hemiatrophy (parry-romberg syndrome)Michele Viana, Christine M Glastonbury, Till Sprenger, et al.Brain Research|November 12, 2002
The role of histamine in dural vessel dilationSimon Akerman, David J Williamson, Holger Kaube, et al.European Journal of Pharmacology|October 2, 2002
The effect of anti-migraine compounds on nitric oxide-induced dilation of dural meningeal vesselsSimon Akerman, David J Williamson, Holger Kaube, et al.The Journal of Neuroscience : the Official Journal of the Society for Neuroscience|March 7, 2002
P/Q-type calcium-channel blockade in the periaqueductal gray facilitates trigeminal nociception: a functional genetic link for migraine?Yolande E Knight, Thorsten Bartsch, Holger Kaube, et al.Pageof 51